corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 1968

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Pope John Paul II.
The profit motive behind too much medical research.
Origins 2002 Apr 25; 31:(45):754-5


Abstract:

A conflict of interest in scientific and medical research “between the investigation and correct treatment of illness … and the financial objective of making a profit” was addressed in a papal message to an April 5-6 international conference on conflicts of interest in science and medicine sponsored by the Polish Academy of Sciences. The Vatican released the papal message April 11, which was addressed as a letter to Archbishop Jozef Kowalczyk, apostolic nuncio to Poland. The pope said that “there is a risk that science-based businesses and health care structures can be set up not in order to provide the best possible care for people in accordance with their human dignity but in order to maximize profits and increase business, with a predictable lowering in the quality of service of those unable to pay.” For example, the pope said, the pharmaceutical industry, “driven by the pursuit of profit and catering to what could be called ‘medicine of desires’ … has favored research which as already placed on the world market products contrary to the moral good, including products which are not respectful of procreation and even suppress human life already conceived.” The pope expressed concern about how priorities are set for pharmaceutical research, as well as about cost-containment imperatives in hospital medical care. His letter was written in English. The text follows.

Keywords:
Biomedical Research*/ethics Catholicism* Conflict of Interest* Drug Industry* Embryo Research Publishing Research Support Resource Allocation Social Justice *analysis The Vatican Poland bioethics conflict-of-interest drug company sponsored research profit motive research priorities hospitals ETHICAL ISSUES IN PROMOTION: ETHICS OF TRIALS PROMOTION IN SPECIFIC THERAPEUTIC AREAS: BREAST FEEDING AND CONTRACEPTION SPONSORSHIP: RESEARCH

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.